DESITIN PHARMA A/S: Financial statements 2024
CVR: 19389006
Source: annual report 2024, Danish Business Authority
01/10/2023 – 30/09/2024
DESITIN PHARMA A/S (CVR 19389006) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 2,123,028 and a net result of DKK 285,567 compared with DKK 2,606,443 the year before. That is a decrease of 30.2% compared with the year before. Equity in the 2024 report amounted to DKK 6,755,407. The solvency ratio was 93.8%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 2,123,028
- Profit/Loss
- DKK 285,567
- Equity
- DKK 6,755,407
- Total Assets
- DKK 7,204,999
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 2.1M | 286K | 6.8M | 2 |
| 2023 | - | 3M | 2.6M | 8.6M | 2 |
| 2022 | - | 3.5M | 346K | 6.4M | 2 |
| 2021 | - | 3.8M | 353K | 6.4M | 2 |
| 2020 | - | 4.2M | 430K | 6.1M | 3 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
DESITIN PHARMA A/S has won the tender "Amgros 2025 1.1303.b" issued by Amgros I/S worth 14,267,938 DKK.
As of October 1, 2024, Beierholm Godkendt Revisionspartnerselskab has been appointed auditor of DESITIN PHARMA A/S.
As of October 1, 2024, EMIT P/S has stepped down as auditor of DESITIN PHARMA A/S.
About DESITIN PHARMA A/S
DESITIN PHARMA A/S is a Danish company of the type Aktieselskab based in København V, founded in 1996. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Eli Lønne. The board consists of Philipp Andreas Bloching (chair), Eli Lønne and Oliver Christoph. The company is owned by Desitin Arzneimittel GmbH. The company has 1 employee (2026). In 2026, the company reported a gross profit of DKK 3,230,179 and a net result of DKK 350,332 compared with DKK 288,733 the year before. Equity in the 2026 report amounted to DKK 7,394,472.